| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥5166.4B | ¥5046.1B | +2.4% |
| Operating Income | ¥-54.5B | ¥276.1B | +0.1% |
| Profit Before Tax | ¥-176.2B | ¥267.9B | -0.5% |
| Net Income | ¥-215.8B | ¥173.4B | +1.5% |
| ROE | -4.7% | 3.5% | - |
FY2026 Q2 results: Revenue ¥5,166.4B (YoY +2.4%), Operating Income ¥-54.5B (loss compared to prior year profit of ¥276.1B), Net Income ¥-215.8B (loss compared to prior year profit of ¥173.4B), representing a significant performance deterioration. The company shifted from profitability to operating loss, driven by substantial impairment losses of ¥378.3B and elevated other expenses of ¥400.2B. Despite revenue growth, gross profit margin improved to 22.5% from prior levels, but SG&A expenses of ¥870.1B (16.8% of revenue) prevented operating profitability. Operating cash flow remained positive at ¥446.2B (YoY -7.1%), generating free cash flow of ¥122.8B after capital expenditures of ¥364.2B. The company maintains full-year revenue guidance of ¥11,500.0B with operating income forecast of ¥140.0B (YoY -77.2%) and anticipates full-year net loss of ¥100.0B, indicating significant second-half recovery requirements.
Revenue increased 2.4% to ¥5,166.4B, with segment contributions from Digital and Industry at ¥1,599.9B (largest segment representing approximately 31% of total revenue), Health and Safety at ¥1,219.0B (24%), Agriculture and Foods at ¥891.6B (17%), and Energy Solutions at ¥398.2B (8%). The modest revenue growth reflects stable demand across core business segments despite challenging market conditions. Gross profit improved to ¥1,164.3B with margin expansion to 22.5%, indicating effective cost management at the production level. However, SG&A expenses reached ¥870.1B (16.8% of revenue), limiting operating leverage benefits from revenue growth.
Operating income deteriorated sharply to ¥-54.5B from prior year profit of ¥276.1B, primarily driven by non-recurring impairment losses of ¥378.3B related to goodwill write-downs. Other expenses totaled ¥400.2B, substantially exceeding other income of ¥28.3B, creating a net drag of ¥371.9B on operating results. Finance costs of ¥151.2B significantly exceeded finance income of ¥29.4B, reflecting the burden of interest-bearing debt totaling ¥4,235.6B (current ¥1,004.6B plus non-current ¥3,230.9B). Equity method income contributed ¥23.2B, providing partial offset.
The gap between operating income (¥-54.5B) and net income (¥-215.8B) widened to ¥161.3B, explained by the net non-operating loss of ¥121.8B (finance costs minus income, plus other expenses minus income) and income tax expense of ¥39.6B despite pre-tax losses, suggesting tax adjustments or non-deductible expenses. The substantial goodwill impairment represents a non-recurring factor, as goodwill decreased 35.9% from ¥785.8B to ¥503.6B year-over-year. This pattern represents revenue up/profit down, with revenue growth failing to translate into profitability due to elevated operating expenses, non-recurring impairments, and heavy financial costs.
Digital and Industry segment generated revenue of ¥1,599.9B, representing the core business at approximately 31% of total revenue. Health and Safety contributed ¥1,219.0B (24% share), Agriculture and Foods ¥891.6B (17% share), and Energy Solutions ¥398.2B (8% share). Operating income data by segment is not disclosed in the available financial statements, preventing detailed profitability analysis by segment. The Digital and Industry segment's scale positions it as the primary revenue driver, while the diversified portfolio across health, agriculture, and energy solutions provides business stability. Without segment-level operating margins, comparison of profitability across divisions cannot be performed, though the overall company operating margin of -1.1% indicates at least one or more segments are experiencing significant profit challenges or that corporate costs are disproportionately high relative to segment contributions.
[Profitability] ROE of -4.7% deteriorated sharply from positive territory in prior year, reflecting net loss impact on equity returns. Operating margin of -1.1% represents significant contraction from prior year's positive 5.5% (calculated as ¥276.1B / ¥5,046.1B), driven by ¥378.3B impairment losses and elevated other expenses. Net profit margin of -4.2% compares unfavorably to manufacturing industry median of 5.4%, positioning the company in the bottom quartile. Gross profit margin of 22.5% shows modest improvement, indicating core production efficiency remains intact despite downstream profit challenges. [Cash Quality] Cash and equivalents of ¥637.9B provide coverage of 0.63x against current bonds and borrowings of ¥1,004.6B, indicating limited short-term debt servicing capacity from cash reserves alone. Operating cash flow of ¥446.2B represents -2.07x conversion ratio against net income of ¥-215.8B, flagging earnings quality concerns as cash generation significantly diverges from accounting profits. [Investment Efficiency] Total asset turnover of 0.45 (calculated as ¥5,166.4B annualized / ¥11,534.0B) falls below manufacturing industry median of 0.36, suggesting relatively efficient asset utilization despite profit challenges. Return on assets of -1.9% reflects net loss impact on asset productivity. [Financial Health] Equity ratio of 38.5% (¥4,594.6B / ¥11,534.0B) sits below manufacturing industry median of 48.6%, indicating higher financial leverage. Debt-to-equity ratio of 1.51 (total liabilities ¥6,939.5B / equity ¥4,594.6B) reflects substantial leverage but remains below critical 2.0x threshold. Financial leverage of 2.51x exceeds industry median of 1.72x, amplifying returns during profitable periods but magnifying losses currently.
Operating cash flow of ¥446.2B represents -2.07x of net income, confirming significant divergence between accounting losses and cash generation capacity, primarily attributable to non-cash impairment charges of ¥378.3B. Operating cash flow before working capital changes reached ¥570.9B, with working capital movements creating ¥-124.7B drag. Specifically, payables decreased ¥240.1B, indicating supplier payment outflows that reduced cash, while receivables changes contributed ¥256.4B inflow, though this paradoxically reflects increased receivables balance (cash outflow in operating activities) that signals collection challenges. Income taxes paid of ¥121.4B and interest paid of ¥22.3B represent cash outflows for financial obligations. Investing cash flow of ¥-323.4B was primarily driven by capital expenditures of ¥364.2B, indicating continued investment in productive capacity despite profit challenges. Financing cash flow of ¥-222.0B reflected dividend payments of ¥97.7B and no share repurchases, with net debt repayment activities. Free cash flow of ¥122.8B (operating CF minus investing CF) provides ¥25.0B cushion after dividends, though this margin is narrow. Contract liabilities increased ¥58.0B, representing advance customer payments that boost liquidity, while contract assets increased ¥39.0B, representing unbilled revenue. Cash position decreased ¥101.0B year-over-year to ¥637.9B, reflecting cash consumption despite positive operating cash flow, driven by investment and financing activities.
Ordinary income equivalent (approximated as operating income plus finance income/costs and equity method income) totals approximately ¥-152.9B (¥-54.5B operating loss, minus ¥121.8B net finance costs, plus ¥23.2B equity method income) versus net loss of ¥-215.8B, indicating ¥-62.9B additional deterioration from other items and taxes. Non-operating components consist primarily of finance costs of ¥151.2B (interest expense on ¥4,235.6B debt), partially offset by finance income of ¥29.4B (including interest and dividend income of ¥3.6B and ¥15.5B respectively) and equity method gains of ¥23.2B from associated investments of ¥395.4B. Other expenses of ¥400.2B represent 7.7% of revenue, an unusually high level suggesting significant non-recurring restructuring, legal, or asset disposal costs beyond the disclosed ¥378.3B impairment. Operating cash flow of ¥446.2B substantially exceeds net income on an absolute basis, but the negative net income creates a distorted ratio of -2.07x. The positive operating cash flow despite accounting losses indicates that non-cash charges (primarily impairments) dominate the P&L, suggesting underlying operational cash generation remains functional. However, receivables turnover of 142 days versus industry median of 105 days and inventory turnover of 94 days signal working capital efficiency challenges that could compress future cash conversion if not addressed.
Full-year guidance projects revenue of ¥11,500.0B, operating income of ¥140.0B (YoY -77.2%), and net loss of ¥100.0B with annual dividend maintained at ¥37.50. Current H1 progress shows revenue of ¥5,166.4B achieving 44.9% of full-year target (below standard 50% H1 pace), and operating loss of ¥-54.5B represents negative progress requiring ¥194.5B second-half operating income to achieve full-year ¥140.0B target. This implies H2 operating income must reach approximately ¥195B, representing a dramatic turnaround from H1 loss. The company revised forecasts during the quarter, though specific revision details are not disclosed in the forecast notes. Key assumptions per forecast notes indicate that projections are based on currently available information and reasonable assumptions, with actual results potentially differing materially due to various factors. The substantial gap between H1 results and implied H2 requirements suggests aggressive cost reduction, revenue acceleration, or elimination of non-recurring losses is embedded in guidance. With current operating margin of -1.1%, achieving full-year operating margin of 1.2% (¥140.0B / ¥11,500.0B) requires sustained operational improvement. Progress rate deviation of -5.1 percentage points below standard pace (44.9% vs. 50%) for revenue warrants monitoring, though typical seasonality patterns may account for some variance.
Annual dividend forecast of ¥37.50 per share represents continuation from prior year levels despite net loss position. With forecasted net loss of ¥100.0B and approximately 230 million shares outstanding, the dividend payout represents approximately ¥8.6B total distribution. Given forecasted net loss, the payout ratio is not meaningful on an earnings basis. However, measured against free cash flow of ¥122.8B (annualized to approximately ¥246B assuming similar H2 generation), the dividend represents approximately 3.5% of annual FCF, indicating cash flow sustainability. Actual H1 dividends paid totaled ¥97.7B per cash flow statement, suggesting semi-annual distribution patterns. No share buybacks were executed (¥0.0B per cash flow statement). The total return ratio on an FCF basis approximates 39.6% (¥97.7B dividends / ¥246B estimated annual FCF), indicating substantial capital return despite profitability challenges. The commitment to maintain dividends at ¥37.50 despite net losses signals management confidence in business recovery and cash generation sustainability, though this policy bears monitoring if losses persist beyond current forecasts.
Impairment recurrence risk: Goodwill balance of ¥503.6B remains substantial after ¥378.3B impairment, with intangible assets of ¥361.8B additional. Combined at ¥865.4B representing 7.5% of total assets, future impairments could materialize if acquired business performance deteriorates further, particularly given the 35.9% goodwill reduction already taken this period.
Working capital deterioration risk: Receivables turnover of 142 days (significantly above industry median of 105 days) combined with trade receivables of ¥2,012.6B represents 39% of revenue, indicating collection challenges. Further DSO expansion would constrain cash generation and could necessitate increased borrowing to fund operations.
Debt servicing capacity risk: Finance costs of ¥151.2B against operating cash flow of ¥446.2B represents 33.9% interest burden. With total interest-bearing debt of ¥4,235.6B and limited cash coverage ratio of 0.63x for current maturities, refinancing risk emerges if operating cash flow deteriorates or credit conditions tighten.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE of -4.7% substantially underperforms manufacturing industry median of 4.4% (IQR: 1.4%-8.7%), placing the company in the bottom quartile primarily due to current period net losses. Operating margin of -1.1% falls well below industry median of 8.8% (IQR: 3.0%-11.0%), indicating significant operational challenges relative to peers. Net profit margin of -4.2% compares unfavorably to industry median of 5.4% (IQR: 1.1%-8.2%).
Financial Health: Equity ratio of 38.5% sits below industry median of 48.6% (IQR: 26.7%-65.2%), indicating higher leverage positioning in the lower half of the industry distribution. Financial leverage of 2.51x exceeds industry median of 1.72x (IQR: 1.51x-3.63x), consistent with higher debt utilization.
Efficiency: Asset turnover of 0.45 exceeds industry median of 0.36 (IQR: 0.32-0.39), demonstrating superior asset utilization efficiency and ranking in the upper quartile. Operating working capital turnover cycle warrants improvement, with receivables at 142 days versus industry median of 105 days (IQR: 76-217 days) and inventory at 94 days versus industry median of 261 days (with the company performing better on inventory efficiency).
Cash Quality: Cash conversion ratio of -2.07 falls below industry median of 0.91 (IQR: -1.33-1.19), reflecting current period earnings quality challenges, though the negative net income base distorts this metric.
Growth: Revenue growth of 2.4% underperforms industry median of 11.7% (IQR: -5.4%-28.3%), positioning the company in the lower half of growth distribution, indicating market share challenges or mature market exposure relative to faster-growing peers.
※ Industry: Manufacturing (7 companies), Comparison: FY2025-Q2 period, Source: Proprietary analysis
Major structural adjustment underway reflected in record impairment: The ¥378.3B goodwill impairment representing 48.1% of prior goodwill balance signals fundamental reassessment of M&A portfolio value and future earning power of acquired businesses. This magnitude of write-down, reducing goodwill from ¥785.8B to ¥503.6B, indicates previous acquisition assumptions have not materialized, requiring investor scrutiny of remaining ¥503.6B goodwill for additional impairment risk. The company's willingness to recognize losses suggests management accountability, though execution risk on turnaround remains elevated.
Cash generation resilience despite accounting losses provides operational foundation: Operating cash flow of ¥446.2B maintaining positive territory despite ¥215.8B net loss demonstrates underlying business continues generating cash from operations. The -2.07x OCF/NI ratio, while flagging earnings quality concerns in normal circumstances, actually reflects non-cash impairment impact rather than operational deterioration. Free cash flow of ¥122.8B after ¥364.2B capex demonstrates continued investment capacity while supporting ¥97.7B dividend distribution, though margin of safety has compressed significantly.
Working capital efficiency deterioration threatens cash conversion sustainability: Receivables turnover of 142 days (35% worse than 105-day industry median) combined with ¥2,012.6B receivables balance representing 142 days of revenue indicates collection cycle extension. Simultaneously, payables decreased ¥240.1B, suggesting reduced supplier credit utilization. These trends, if sustained, could reverse positive operating cash flow despite operational improvements, requiring management focus on receivables collection and payables optimization to prevent liquidity pressure given limited 0.63x cash coverage of current debt maturities.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.